Search Count: 8
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2015-09-30 Classification: OXIDOREDUCTASE Ligands: NAD, MG, HRW |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2015-09-30 Classification: OXIDOREDUCTASE Ligands: NAD, MG, KI5 |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2015-09-30 Classification: OXIDOREDUCTASE Ligands: NAD, MG, 1PE, A0C |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2015-09-30 Classification: OXIDOREDUCTASE Ligands: NAD, UUD, ACT |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2015-09-30 Classification: OXIDOREDUCTASE Ligands: NAD, KXU |
 |
Optimisation Of Pyrroleamides As Mycobacterial Gyrb Atpase Inhibitors: Structure Activity Relationship And In Vivo Efficacy In The Mouse Model Of Tuberculosis
Organism: Mycobacterium smegmatis
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2013-10-30 Classification: ISOMERASE Ligands: CA, RWX, SO4 |
 |
Organism: Streptococcus pneumoniae
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2013-10-16 Classification: ISOMERASE/ISOMERASE INHIBITOR Ligands: SO4, 28F |
 |
Organism: Streptococcus pneumoniae
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2013-10-16 Classification: ISOMERASE/ISOMERASE INHIBITOR Ligands: 28G |